Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings

Author(s): Kern, R. S., Marshall, B. D., Green, M. F.

Journal/Book: Schizophr Res. 1998; 31: PO Box 211, 1000 AE Amsterdam, Netherlands. Elsevier Science BV. 159-165.

Abstract: Currently, little is known about the pharmacological effects of the new generation of antipsychotic medications on perception of emotion in schizophrenia. The present study was designed to compare the effects of risperidone versus haloperidol on the ability to perceive emotion in 20 treatment-resistant schizophrenia patients, using a double-blind design. Measures of emotion perception included a facial emotion identification test (still photographs presented on videotape), a voice emotion identification test (audiotape), and an affect perception lest (brief interpersonal vignettes presented on videotape). These measures were administered during the final week of baseline and after 8 weeks of double-blind medication. Risperidone treatment produced a greater effect cn patients' ability to perceive emotion compared with haloperidol treatment. Additionally, all patients who received risperidone demonstrated improvement in performance between baseline and retest, compared with four of the nine patients who received haloperidol. When changes in positive symptoms were statistically controlled, the results remained significant. These findings suggest that risperidone may facilitate patients' ability to accurately perceive emotion, an effect which may be mediated either directly by risperidone's pharmacological action or perhaps indirectly by its influence on basic neurocognition.

Note: Article Kee KS, W Los Angeles Vet Affairs Med Ctr, 11301 Wilshire Blvd, 116AR, Bldg 208, Los Angeles,CA 90073 USA

Keyword(s): risperidone; haloperidol; emotion perception; schizophrenia; GENERALIZED POOR PERFORMANCE; SOCIAL SKILL; RECOGNITION; DISORDERS

Zurück | Weiter